Neutrophil Extracellular Trap Targeting Protects Against Ischemic Damage After Fibrin-Rich Thrombotic Stroke Despite Non-Reperfusion

Stroke is one of the most prevalent diseases worldwide caused primarily by a thrombotic vascular occlusion that leads to cell death. To date, t-PA (tissue-type plasminogen activator) is the only thrombolytic therapy approved which targets fibrin as the main component of ischemic stroke thrombi. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Peña-Martínez, Carolina, Durán-Laforet, Violeta, García-Culebras, Alicia, Cuartero, María Isabel, Moro, María Ángeles, Lizasoain, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888409/
https://www.ncbi.nlm.nih.gov/pubmed/35250974
http://dx.doi.org/10.3389/fimmu.2022.790002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888409/
https://www.ncbi.nlm.nih.gov/pubmed/35250974
http://dx.doi.org/10.3389/fimmu.2022.790002

Ejemplares similares